MedPageToday -- The sleep disturbances common among patients with ankylosing spondylitis improved significantly during treatment with the tumor necrosis factor (TNF)-blocking drug golimumab (Simponi), a secondary analysis showed.
MedPageToday -- The sleep disturbances common among patients with ankylosing spondylitis improved significantly during treatment with the tumor necrosis factor (TNF)-blocking drug golimumab (Simponi), a secondary analysis showed.